solid and hematological malignancies

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Antigen Expression Profiling and HLA Typing for

Recruiting
  • Solid and Hematological Malignancies
    • Duarte, California
    • +34 more
    Aug 23, 2022

    Solid and Hematological Malignancies Trial in United States (Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, KITE-585)

    Enrolling by invitation
    • Solid and Hematological Malignancies
    • Axicabtagene Ciloleucel
    • Brexucabtagene Autoleucel (KTE-X19)
    • Duarte, California
    • +7 more
    Jun 29, 2022

    Solid and Hematological Malignancies Trial in Berlin (Capivasertib, Rabeprazole)

    Completed
    • Solid and Hematological Malignancies
    • Berlin, Germany
      Research Site
    May 6, 2022

    Subjects Exposed to Genetically Engineered T Cell Receptors

    Terminated
    • Solid and Hematological Malignancies
    • Genetically engineered T Cell Receptors
    • Nashville, Tennessee
    • +2 more
    Jan 5, 2021